Frankfurt - Delayed Quote EUR
Ascentage Pharma Group International (36X.F)
4.7600
0.0000
(0.00%)
As of April 22 at 9:59:01 AM GMT+2. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 7 |
| Avg. Estimate | -- | -- | 532.98M | 2.68B |
| Low Estimate | -- | -- | 422.96M | 1.82B |
| High Estimate | -- | -- | 622M | 2.99B |
| Year Ago Sales | -- | -- | 980.65M | 532.98M |
| Sales Growth (year/est) | -- | -- | -45.65% | 402.91% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 36X.F | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Related Tickers
2160.T GNI Group Ltd.
2,200.00
+0.46%
GYRE Gyre Therapeutics, Inc.
8.64
+2.86%
ERAS Erasca, Inc.
1.3800
+11.29%
PULM Pulmatrix, Inc.
6.31
+2.44%
OLMA Olema Pharmaceuticals, Inc.
4.9600
+4.42%
IMAB I-Mab
0.8304
-2.88%
ONC BeiGene, Ltd.
252.77
+10.27%
LEGN Legend Biotech Corporation
34.48
+6.95%
APLS Apellis Pharmaceuticals, Inc.
17.37
-3.66%
MDGL Madrigal Pharmaceuticals, Inc.
302.72
+2.61%